BIGGIOGGERO, MARTINA

BIGGIOGGERO, MARTINA  

Dipartimento di Scienze Cliniche e di Comunità  

Mostra records
Risultati 1 - 20 di 48 (tempo di esecuzione: 0.001 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: Focus on interchangeability 2017 Becciolini A.Raimondo M. G.Crotti C.Agape E.Biggioggero M.Favalli E. G. Article (author) -
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy 2004 R. CimazM. BiggioggeroO. BorghiP. L. Meroni + Article (author) -
Arthritis and infections 2005 R. CimazE. MeregalliM. BiggioggeroP. Careddu + Article (author) -
Baricitinib for COVID-19: a suitable treatment? 2020 Favalli E. G.Biggioggero M.Maioli G.Caporali R. Article (author) -
Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic 2021 Favalli E. G.Maioli G.Biggioggero M.Caporali R. Article (author) -
Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights 2021 Raimondo M. G.Biggioggero M.Coletto L. A.Caporali R.Favalli E. G. + Article (author) -
Comment on : Bisphosphonates and osteonecrosis of the jaw 2008 M. Biggioggero + Article (author) -
Cutting-Edge Issues in Coronary Disease and the Primary Antiphospholipid Syndrome 2013 R. GualtierottiM. BiggioggeroP. Meroni Article (author) -
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients : Results from the GISEA register 2014 Favalli, Ennio GiulioSarzi-Puttini, PiercarloBiggioggero, Martina + Article (author) -
Eight-year retention rate of first-line tumor necrosis factor inhibitors in spondyloarthritis : A multi-center retrospective analysis 2016 E. G. FavalliC. SelmiA. BeccioliniM. Biggioggero + Article (author) -
IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors 2007 R. CimazM. BiggioggeroF. Fantini + Article (author) -
Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants 2007 M. BiggioggeroM.O. BorghiM. GerosaL. TrespidiR. CimazP.L. Meroni Article (author) -
Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations 2022 Favalli, Ennio GiulioZagato, ElenaMaioli, GabriellaPesce, ElisaDonnici, LorenaBiggioggero, MartinaCurti, SerenaManganaro, LaraBevilacqua, ValeriaMartinovic, MartinaMarongiu, LauraNotarbartolo, SamueleBandera, AlessandraGori, AndreaDe Francesco, RaffaeleAbrignani, SergioCaporali, Roberto + Article (author) -
Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis 2020 Favalli E. G.Biggioggero M.De Lucia O.Murgo A.Caporali R. + Article (author) -
Is there a need for new thresholds to define remission and low disease activity by disease activity score 28 calculated with C reactive protein? real life data from a local registry 2015 Favalli E. G.Becciolini A.Biggioggero M.Meroni P. L. + Article (author) -
Is there really room for anti-rheumatic drugs in the treatment of COVID-19? 2020 Favalli, E GIngegnoli, FBiggioggero, MCaporali, R Article (author) -
Juvenile idiopathic arthritis in adulthood in a tertiary reference centre 2008 A. SalmasoB. TeruzziM. BiggioggeroF. Fantini + Article (author) -
Methotrexate for the treatment of rheumatoid arthritis in the biologic era: Still an "anchor" drug? 2014 Favalli E. G.Biggioggero M.Meroni P. L. Article (author) -
Osteoporosis 2001 R. CimazM. Biggioggero Article (author) -
Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors 2020 Bodio C.Grossi C.Favalli E. G.Biggioggero M.Caporali R.Sarzi-Puttini P.Meroni P. L.Borghi M. O. + Article (author) -